At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease
Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the
forecast year 2020-2030.
Peripheral artery disease is a common circulatory problem that causes narrowing of the
peripheral arteries. Generally, it affects arteries in the legs and sometimes affect the arteries
carrying blood from heart to arms, kidneys, head, and stomach. It is mainly caused by the
deposition of fats or plaques in the artery walls. The exercise, tobacco cessation, and a
healthy diet are the main treatments for this disease; however, when such treatments aren't
enough, medication or surgery can be helpful.
Access Full Description of this report at:-
Top Companies: Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc.,
Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips
N.V, AngioDynamics, Inc., Biotronik and others.
The global peripheral artery disease market share is segmented on the basis of type, and
geography. On the basis of type, the market is segmented into peripheral angioplasty
balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque
modification devices, hemodynamic flow alteration devices, and peripheral accessories.
Geographic fragmentation and analysis of each segment includes regions comprising North
America, Europe, Asia Pacific and RoW.
Request sample copy of this report at:-
In terms of geography, North America held major share of the market in 2019. This is
attributed to higher healthcare expenditure and the growing occurrence of minimally
invasive surgeries in the region. However, Asia-pacific is expected to be the fastest growing
market due to the existence of large patient pool along with unmet medical needs.
Moreover, significant growth in pop